Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cancer metabolic reprogramming and immune response
Longzheng Xia, Linda Oyang, Jinguan Lin, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 710

Showing 1-25 of 710 citing articles:

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 242
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 234
Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts
Ting Li, Yue‐Tao Tan, Yan‐Xing Chen, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 501-511
Open Access | Times Cited: 113
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 109
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 106
Estrogen Receptor Signaling in the Immune System
Binita Chakraborty, Jovita Byemerwa, Taylor Krebs, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 117-141
Open Access | Times Cited: 100
Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis
Yang Liu, Bo Wang, Junjie Zhu, et al.
Advanced Materials (2022) Vol. 35, Iss. 9
Closed Access | Times Cited: 94
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 89
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Shiqi Nong, Xiaoyue Han, Xiang Yu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 87
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Wenjun Mao, Yun Cai, Danrong Chen, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 85
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 83
PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
Liliang Shen, Junfeng Zhang, Zongtai Zheng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5459-5474
Open Access | Times Cited: 82
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
Qihang Yuan, Dawei Deng, Pan Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 75
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
Carla Navarro, Ángel Ortega, Raquel Santeliz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1303-1303
Open Access | Times Cited: 73
Spatial multi-omics analyses of the tumor immune microenvironment
Wan-Chen Hsieh, Bugi Ratno Budiarto, Yi‐Fu Wang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 70
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1071-1071
Open Access | Times Cited: 68
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 54
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 52
The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape
Diandra Zipinotti dos Santos, Josiany Carlos de Souza, Tatiana Massariol Pimenta, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 51
HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
Jiancheng Lv, Kai Li, Hao Yu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 50
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes
Jingwen Xiong, Hao Chi, Guanhu Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 45
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Xuanzhang Huang, Min-Jiao Pang, Jiayi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top